The severity and rapid spread of COVID-19 (caused by SARS-CoV-2) have raised questions about the use of some drugs in patients with the disease and whether currently available drugs could be effective in treating it. Definitive answers are lacking, but some recommendations can be made. Updated information on COVID-19 is available from the CDC at www.cdc.gov/coronavirus/2019-ncov/hcp/index.html.
ACES AND ARBS — Patients with cardiovascular disease are at increased risk of...
- Drugs for Irritable Bowel Syndrome
- Table: Safety of Drugs for IBS in Pregnancy and Lactation (online only)
- Addendum: Drospirenone (Slynd) - A New Progestin-Only Oral Contraceptive
The FDA has approved two new drugs for sickle cell disease: crizanlizumab-tmca (Adakveo – Novartis), an IV P-selectin blocker, and voxelotor (Oxbryta – GBT), an oral hemoglobin S (HbS) polymerization inhibitor.
STANDARD TREATMENT — In sickle cell disease, elongated or sickle-shaped red blood cells obstruct small blood ...
